IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
| Revenue (Most Recent Fiscal Year) | $4.30B |
| Net Income (Most Recent Fiscal Year) | $1.06B |
| PE Ratio (Current Year Earnings Estimate) | 40.34 |
| PE Ratio (Trailing 12 Months) | 44.91 |
| PEG Ratio (Long Term Growth Estimate) | 3.56 |
| Price to Sales Ratio (Trailing 12 Months) | 10.85 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 29.20 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 38.91 |
| Pre-Tax Margin (Trailing 12 Months) | 30.77% |
| Net Margin (Trailing 12 Months) | 24.62% |
| Return on Equity (Trailing 12 Months) | 69.78% |
| Return on Assets (Trailing 12 Months) | 31.91% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.23 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.90 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.23 |
| Inventory Turnover (Trailing 12 Months) | 4.22 |
| Book Value per Share (Most Recent Fiscal Quarter) | $20.10 |
| Earnings per Share (Most Recent Fiscal Quarter) | $3.08 |
| Earnings per Share (Most Recent Fiscal Year) | $13.08 |
| Diluted Earnings per Share (Trailing 12 Months) | $13.07 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 79.52M |
| Free Float | 78.74M |
| Market Capitalization | $46.68B |
| Average Volume (Last 20 Days) | 0.51M |
| Beta (Past 60 Months) | 1.66 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.98% |
| Percentage Held By Institutions (Latest 13F Reports) | 87.84% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |